Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: John W. Andrews who wrote (11470)	7/14/1998 8:20:00 PM
From: VLAD	Read Replies (3) \| Respond to of 23519

<<refills are unlikely to become users>> Don't count on it. As Edderd has explained, many of the psycogenic cases will eventually fail once the placebo effect wears off. Based on your info on Viagra percentage changes on script data I get New = 129,200 Refill = 85,595 Total = 214,795 So new scripts are now down for the 8th week in a row and so are the total script numbers. When the new scripts stop going down and the refills stop going up we will have an idea of how well Viagra does post hype.